Rite Zone Chemcon India (RITEZONE)₹18.30−2.66%Specialty Chemicals
In the Mar 2026 quarter (standalone), Rite Zone Chemcon India reported sales of ₹13.75 Cr, up 15.4% from Mar 2025, and net profit of ₹0.15 Cr, down 44.4% year on year. For the year to Mar 2026, sales were ₹25.47 Cr and net profit ₹0.33 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 12.09 | 10.77 | 15.87 | 14.22 | 11.91 | 11.71 | 13.75 |
| Expenses | 11.21 | 10.12 | 15.01 | 13.39 | 11.56 | 11.41 | 13.49 |
| Operating Profit | 0.91 | 0.69 | 0.93 | 0.87 | 0.38 | 0.36 | 0.30 |
| OPM % | 7.4% | 6.5% | 5.8% | 6.0% | 3.1% | 3.0% | 2.2% |
| Other Income | 0.00 | 0.06 | 0.12 | 0.04 | 0.20 | 0.09 | 0.20 |
| Interest | 0.04 | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | 0.06 |
| Depreciation | 0.09 | 0.14 | 0.15 | 0.13 | 0.15 | 0.13 | 0.14 |
| Profit before tax | 0.78 | 0.59 | 0.87 | 0.75 | 0.39 | 0.28 | 0.31 |
| Tax % | 15.5% | 32.7% | 16.3% | 17.5% | 28.9% | 33.3% | 43.3% |
| Net Profit | 0.65 | 0.39 | 0.72 | 0.61 | 0.27 | 0.17 | 0.15 |
| EPS (Rs) | 1.55 | 0.94 | 1.72 | 1.46 | 0.65 | 0.42 | 0.37 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 5.73 | 3.79 | 4.91 | 22.41 | 26.63 | 26.13 | 25.47 |
| Expenses | 5.19 | 3.54 | 4.81 | 21.03 | 25.11 | 24.96 | 24.89 |
| Operating Profit | 0.56 | 0.26 | 0.14 | 1.43 | 1.63 | 1.24 | 0.65 |
| OPM % | 9.6% | 7.1% | 2.6% | 6.3% | 6.1% | 4.7% | 2.6% |
| Other Income | −0.09 | 0.05 | 0.72 | 0.04 | 0.17 | 0.23 | 0.28 |
| Interest | 0.13 | 0.11 | 0.09 | 0.09 | 0.06 | 0.06 | 0.10 |
| Depreciation | 0.22 | 0.19 | 0.24 | 0.27 | 0.27 | 0.26 | 0.26 |
| Profit before tax | 0.13 | 0.02 | 0.52 | 1.10 | 1.46 | 1.14 | 0.58 |
| Tax % | −33.4% | 99.9% | 54.8% | 23.8% | 22.1% | 20.3% | 38.6% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 0.15 | 0.00 | 0.22 | 0.82 | 1.12 | 0.88 | 0.33 |
| EPS (Rs) | 159.57 | 9.98 | 0.75 | 1.95 | 2.66 | 2.09 | 0.79 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.00 | 0.00 | 3.03 | 4.22 | 4.22 | 4.22 | 4.22 |
| Reserves | 0.63 | 0.61 | 1.97 | 8.84 | 9.95 | 10.84 | 11.18 |
| Borrowings | 2.58 | 3.28 | 1.07 | 0.92 | 0.79 | 0.95 | 1.59 |
| Other Liabilities | 3.44 | 2.87 | 5.17 | 5.18 | 4.79 | 5.51 | 5.62 |
| Total Liabilities | 6.65 | 6.76 | 11.24 | 19.16 | 19.75 | 21.52 | 22.61 |
| Fixed Assets | 1.36 | 2.12 | 2.08 | 1.86 | 1.77 | 1.83 | 1.72 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.44 |
| Other Assets | 5.29 | 4.64 | 9.16 | 17.30 | 17.98 | 19.69 | 18.45 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.08 | 0.03 | 0.06 | 0.08 |
| Trade receivables | 5.10 | 4.40 | 8.67 | 9.59 | 11.04 | 12.71 | 13.22 |
| Cash & equivalents | 0.13 | 0.17 | 0.38 | 3.58 | 2.73 | 2.46 | 0.46 |
| Total Assets | 6.65 | 6.76 | 11.24 | 19.16 | 19.75 | 21.52 | 22.61 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | −0.26 | 1.08 | −3.61 | −3.85 | −0.51 | −0.02 | 0.65 |
| Cash from investing activity | 0.33 | −0.94 | −0.20 | −0.05 | −0.18 | −0.32 | −0.24 |
| Cash from financing activity | −0.13 | −0.11 | 4.01 | 7.09 | −0.15 | 0.07 | −0.06 |
| Net cash flow | −0.10 | 0.05 | 0.22 | 3.21 | −0.86 | −0.28 | 0.37 |
| Capex | 0.00 | 0.92 | 0.18 | 0.03 | 0.16 | 0.30 | 0.14 |
| Free cash flow | 0.04 | 0.15 | −3.80 | −3.88 | −0.68 | −0.33 | 0.50 |
| CFO / OP % | −39.9% | 407.1% | −2,661.9% | −252.9% | −9.0% | 20.0% | 135.1% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor days | 322 | 421 | 639 | 154 | 149 | 176 | 188 |
| Inventory days | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
| Days payable | — | — | — | 91 | 77 | 89 | 95 |
| Cash conversion cycle | 324 | 423 | 641 | 68 | 76 | 91 | 97 |
| Working capital days | 91 | 143 | 260 | 134 | 139 | 159 | 164 |
| ROCE % | — | 3.6% | 12.4% | 11.9% | 10.5% | 7.7% | 4.1% |
For the Mar 2026 quarter, Rite Zone Chemcon India reported sales of ₹13.75 Cr, up 15.4% year on year and net profit of ₹0.15 Cr, down 44.4% year on year. The operating margin was 2.2%.
Rite Zone Chemcon India's sales for the year to Mar 2026 were ₹25.47 Cr.
Net profit for the year to Mar 2026 was ₹0.33 Cr. Earnings per share over the same trailing period were ₹0.79.
Rite Zone Chemcon India reported borrowings of ₹1.59 Cr at Mar 2026, against cash and equivalents of ₹0.46 Cr.
Cash from operations was ₹0.65 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.50 Cr.